The overall goal of these studies is to understand how the HM genes regulate immune responses. The TIM gene family, discovered by our group in 2001 using a positional cloning strategy in congenic mice, potently regulates innate and adaptive immune responses. In the previous grant period, we showed that TIM-1 is an important costimulatory molecule for T cells and an important susceptibility gene for atopic diseases, and that TIM-4 and TIM-1 function as receptors for phosphatidylserine (PtdSer). a critical marker of apoptotic cells. The current Program Project builds on these seminal findings, and consists of four interconnected and complementary Projects focusing on different aspects of TIM interactions with PtdSer expressed by apoptotic cells. The overall hypothesis is that the TIMs function as pattern recognition receptors that sense PtdSer as a DAMP (damage associated molecular pattern), and that the TIMs function either to clear apoptotic cells or to amplify immunity by responding to apoptotic/dying cells. In Project 1, we will study TIM-1 expressing natural killer T (NKT) cells, which function to sense and become activated by apoptotic cells in the liver and in the lungs. In Project 2, we will examine intracellular, molecular and functional consequences of PtdSer on apoptotic cells binding to TIM molecules on antigen presenting cells (APCs) and T cells. In Project 3 we will examine the role of TIMs in in vivo models of respiratory and oral tolerance, in which clearance of apoptotic cells by TIM expressing APCs plays a critical role. In Project 4 we will examine the structure of TIM proteins and the influence ofthe TIM gene polymorphisms on ligand recognition and presentation of ligand binding epitopes. Our Projects utilize unique reagents, including TIM specific mAbs, TIM-1 transgenic, TIM-4 transgenic and TIM-I""""""""''and TIM-3""""""""'"""""""" mice, TIM crystals, monkeys and complementary approaches involving crystallogra?? phy, structural biology, virology, biochemistry as well as cellular and molecular immunology, in models of asthma, hepatitis, respiratory tolerance and oral tolerance. Our studies will demonstrate that the T/Mgene family evolved to sense the presence of apoptotic cells at different phases of immunity, and to play a major role in regulating distinct compartments of mucosal immune responses by affecting cell activation, survival, death and immune tolerance. The results of these studies will greatly impact our understanding of immunity, and may lead to important new therapies for inflammatorv diseases, including asthma and food allergy.
The 7//W genes have been shown to be important disease susceptibility genes (asthma, allergy, atopic dermatitis, food allergy and rheumatoid arthritis) and to potently regulate immune responses. We believe that further study of these molecules will greatly improve our understanding of disease mechanisms, and are likely to lead to novel therapies for asthma and food allergy.
|Morales-Kastresana, Aizea; Telford, Bill; Musich, Thomas A et al. (2017) Labeling Extracellular Vesicles for Nanoscale Flow Cytometry. Sci Rep 7:1878|
|Kamphorst, Alice O; Wieland, Andreas; Nasti, Tahseen et al. (2017) Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science 355:1423-1427|
|Santiago, César; Mudgal, Gaurav; Reguera, Juan et al. (2017) Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection. Sci Rep 7:46045|
|Foks, Amanda C; Engelbertsen, Daniel; Kuperwaser, Felicia et al. (2016) Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol 36:456-65|
|Kim, Hye Young; Umetsu, Dale T; Dekruyff, Rosemarie H (2016) Innate lymphoid cells in asthma: Will they take your breath away? Eur J Immunol 46:795-806|
|Brauner, Eran; Gunda, Viswanath; Vanden Borre, Pierre et al. (2016) Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer. Oncotarget 7:17194-211|
|Mahoney, Kathleen M; Rennert, Paul D; Freeman, Gordon J (2015) Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov 14:561-84|
|Echbarthi, Meriem; Zonca, Manuela; Mellwig, Rachel et al. (2015) Distinct Trafficking of Cell Surface and Endosomal TIM-1 to the Immune Synapse. Traffic 16:1193-207|
|Mahoney, Kathleen M; Freeman, Gordon J; McDermott, David F (2015) The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Clin Ther 37:764-82|
|Xiao, Yanping; Yu, Sanhong; Zhu, Baogong et al. (2014) RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. J Exp Med 211:943-59|
Showing the most recent 10 out of 42 publications